<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Article The UK Coronavirus Cancer Monitoring Project: protecting patients with" exact="cancer" post="in the era of COVID-19 collab: The UK Coronavirus"/>
 <result pre="analyse, and disseminate in real time data from the UK" exact="cancer" post="centres about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"/>
 <result pre="in real time data from the UK cancer centres about" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) infection rates in patients with cancer,"/>
 <result pre="COVID-19 varies from no or minor symptoms akin to the" exact="common cold," post="to severe acute respiratory distress syndrome, resulting in severely"/>
 <result pre="or minor symptoms akin to the common cold, to severe" exact="acute respiratory distress syndrome," post="resulting in severely impaired respiratory function. 1 SARS-CoV-2 is"/>
 <result pre="2·5 million individuals live with, or have a history of," exact="cancer" post="in the UK, with 1000 new diagnoses each day."/>
 <result pre="or are recovering from surgery and complex treatments. Patients with" exact="cancer" post="potentially have increased susceptibility to SARS-CoV-2 infection and have"/>
 <result pre="more serious sequelae, resulting from impaired immune function due to" exact="cancer" post="itself, cancer treatment, or both. 5, 6 Wenhua Liang"/>
 <result pre="sequelae, resulting from impaired immune function due to cancer itself," exact="cancer" post="treatment, or both. 5, 6 Wenhua Liang and colleagues"/>
 <result pre="and colleagues 6 reported their identification of 18 patients with" exact="cancer" post="in a cohort of 1590 patients with COVID-19 in"/>
 <result pre="China, indicating an increased incidence of COVID-19 in patients with" exact="cancer" post="compared with the general Chinese population (1·13% vs 0·29%)."/>
 <result pre="and colleagues 7 who investigated SARS-CoV-2 infection in patients with" exact="cancer" post="at a tertiary care hospital in Wuhan. The incidence"/>
 <result pre="hospital in Wuhan. The incidence of COVID-19 in patients with" exact="cancer" post="(12 [0·79%] of 1524 patients) was higher than in"/>
 <result pre="the general Wuhan population (0·37%). Patients with specific types of" exact="cancer" post="might be at an increased risk of COVID-19, with"/>
 <result pre="both these reports highlighting the high proportion of patients with" exact="lung cancer" post="with confirmed diagnoses of COVID-19 (five of 18 patients"/>
 <result pre="these reports highlighting the high proportion of patients with lung" exact="cancer" post="with confirmed diagnoses of COVID-19 (five of 18 patients"/>
 <result pre="seven of 12 in Yu et al 7 ). Specific" exact="cancer" post="treatments might also differentially contribute to risk of COVID-19."/>
 <result pre="populations, potentially rendering patients more susceptible to infection. Conversely, many" exact="cancer" post="treatments for solid tumours have little effect on lymphocyte"/>
 <result pre="SARS-CoV-2 infection is highly unlikely to affect all patients with" exact="cancer" post="equally. The European Society of Medical Oncology has published"/>
 <result pre="effect of COVID-19 on patients with cancer, by prioritisation of" exact="cancer" post="treatment in patients expected to derive a substantial absolute"/>
 <result pre="stretched health-care resources. However, substantial reallocation of resources away from" exact="cancer" post="care services could potentially have unintended cancer-related implications, including"/>
 <result pre="Therefore, real-time collection, analysis, and dissemination of data from our" exact="cancer" post="centres about SARS-CoV-2 infection rates in patients with cancer,"/>
 <result pre="18, 2020, and aiming to involve over 90% of UK" exact="cancer" post="centres, will achieve this goal. A Local Emergency Response"/>
 <result pre="Emergency Response Reporting Group has been created at each UK" exact="cancer" post="centre to ensure continued updating of the UKCCMP live"/>
 <result pre="dissemination system. The project will collect data on patients with" exact="cancer" post="who are positive for SARS-CoV-2 infection, including tumour type"/>
 <result pre="SARS-CoV-2 infection, including tumour type and stage, patient age, present" exact="cancer" post="treatment, and clinical outcomes, with the aim to enable"/>
 <result pre="Cloud. 10 UKCCMP delivers meaningful real-time data to all UK" exact="cancer" post="centres and clinicians to allow more personalised approaches to"/>
 <result pre="care and inform clinical decision making. This initiative will improve" exact="cancer" post="care in the UK and beyond at this time"/>
 <result pre="W Chua MLK Xie C SARS-CoV-2 transmission in patients with" exact="cancer" post="at a tertiary care hospital in Wuhan, China JAMA"/>
 <result pre="Wu C Chen X Cai Y Risk factors associated with" exact="acute respiratory distress syndrome" post="and death in patients with coronavirus disease 2019 pneumonia"/>
 <result pre="distress syndrome and death in patients with coronavirus disease 2019" exact="pneumonia" post="in Wuhan, China JAMA Intern Med 2020 published online"/>
</results>
